Poststroke Mortality, ADL Dependency Up With Low Socioeconomic Status

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 13, 2023.

By Elana Gotkine HealthDay Reporter

MONDAY, Nov. 13, 2023 -- Stroke patients with low socioeconomic status (SES) have substantially increased risks for death and activities of daily living (ADL) dependency at three months after stroke, according to a study published online Nov. 8 in Neurology.

Anita Lindmark, Ph.D., from Umeå University in Sweden, and colleagues conducted a nationwide register-based cohort study including all 72 hospitals caring for patients with acute stroke in Sweden. The absolute risk for death and ADL dependency at three months was examined depending on SES in a causal mediation analysis.

The researchers found that 26.3 percent of the 25,846 patients in the study were dead or ADL-dependent at three months after stroke. Low SES was associated with increased absolute risks of 5.4 and 10.1 percent compared with mid and high SES, respectively, after adjustment for sex and age. Absolute reductions of 2.2 and 4.0 percent, respectively, would be seen by intervening to shift the distribution of all mediators (comorbidities, stroke severity, and acute care) to those of more privileged groups, with the largest reduction accomplished by equalizing stroke severity.

"Our research suggests that it could be possible to save 40 out of every 1,000 patients in the low socioeconomic group from dying or becoming dependent on others if we could equalize differences between socioeconomic groups," Lindmark said in a statement. "Much of this reduction in risk for people with low socioeconomic status could be accomplished by interventions that could reduce stroke severity."

Abstract/Full Text

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-11-14 03:13

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords